Jaehyun Choi

Chief Executive Officer Genexine

Seminars

Thursday 12th November 2026
Outlining BioPROTAC: A Novel TPD Payload In mRNA Therapy
2:30 pm
  • Unveil an update of EPDegTM bioPROTAC development
  • Discuss the proved differentiating points of bioPROTAC platform from others
  • Learn the current challenges and future directions
Jaehyun Choi - Expert Speaker - 2nd RNA-Based Therapeutics & Vaccines South Korea